# An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia

> **NCT02234583** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 2485 (actual)

## Conditions studied

- Pain Associated With Fibromyalgia

## Interventions

- **DRUG:** DS-5565

## Key facts

- **NCT ID:** NCT02234583
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-04
- **Primary completion:** 2017-04-19
- **Final completion:** 2017-04-19
- **Target enrollment:** 2485 (ACTUAL)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02234583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02234583, "An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02234583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*